Viewing Study NCT00367328



Ignite Creation Date: 2024-05-05 @ 4:59 PM
Last Modification Date: 2024-10-26 @ 9:27 AM
Study NCT ID: NCT00367328
Status: TERMINATED
Last Update Posted: 2015-04-07
First Post: 2006-08-19

Brief Title: To Determine the Efficacy of a Laser Device for the Treatment of Hidradenitis Suppurativa
Sponsor: University of California Davis
Organization: University of California Davis

Study Overview

Official Title: To Determine The Efficacy Of A 1320nm Nd YAG Nonablative Laser For Treatment of Hidradenitis Suppurativa
Status: TERMINATED
Status Verified Date: 2015-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Terminated recruiting or enrolling participants has halted
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: A research study to determine the efficacy of a 1320 nm laser device for the treatment of hidradenitis suppurativa
Detailed Description: Hidradenitis Suppurativa is a chronic scarring disease The treatments available for this condition are not very effective and work only for some patients

Recently a 1320nm laser device has been approved by the FDA for the treatment of acne and facial rejuvenation Given the positive results seen with the use of this laser in the treatment of acne it is reasonable to hypothesize that a similar effect may be seen with the treatment of Hidradenitis suppurativa

The specific aim of the study is to determine the efficacy of this device for the treatment of hidradenitis suppurativa as it relates to the patients established treatment

The investigators are trying to determine the efficacy of a laser for the treatment of hidradenitis suppurativa

Patients will

be examined and interviewed
have photographs taken of the treatment site
have a 4mm punch biopsy performed
have wound culture swabs performed

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None